Respiratory Diseases
2022 Activity indicators
- 2 competitive public led projects.
- 1 private led project.
- 16 led clinical trials.
- 56 publications.
- IF: 490.70.
- Publications in D1: 15 (30 %).
- Publications in Q1: 28 (56 %).
- 1 award
- 2 clinical guides
- Project and scientific communications evaluators: 1 PI.
- Members of editorial committees: 1 PI.
Milestones
- Dr. Jiménez. Coordinator of the Regional Plan for the Management of PTE in the Community of Madrid.
- Jiménez D, et al. Randomized controlled trial of a prognostic assessment and management pathway to reduce the length of hospital stay in normotensive patients with acute pulmonary embolism. Eur Respir J 2022; 59: 2100412. PMID: 34385269
- Dr. Jimenez. Member of the American College of Chest Physycians (ACCP) Panel for the development of the Thromboprophylaxis Guideline for patients with COVID-19.
- Three competitive clinical studies funded by ISCIII (AES) active: PI22/01688 (PI: Dr. Irene Cano); PI20/00369 (PI: Dr. Jiménez); PI18/00172 (PI: Deisy Barrios).
- Dr. Cano: Coordinator of the Sleep and Ventilation Area of the Spanish Society of Pneumology and Thoracic Surgery (SEPAR). (2021-present).
Bibliometrics
| Articles | Accum. IF | Mean IF | Articles Q1 or Q2 | % in Q1 or Q2 | Articles D1 | % in D1 | |
|---|---|---|---|---|---|---|---|
| 2018 | 54 | 263,49 | 4,88 | 43 | 80 | 12 | 22 |
| 2019 | 56 | 315,53 | 5,63 | 41 | 73 | 11 | 20 |
| 2020 | 61 | 414,66 | 6,80 | 51 | 84 | 16 | 26 |
| 2021 | 51 | 497,78 | 9,76 | 58 | 114 | 13 | 25 |
| 2022 | 50 | 490,70 | 9,81 | 46 | 92 | 15 | 30 |
| 272 | 1982,16 | 7,38 | 239 | 88 | 67 | 25 |
*Only original articles, editorials, guidelines and reviews
